Literature DB >> 7351835

Further studies on the prognostic importance of Barr body frequency in human breast cancer: with discussion on its probable mechanism.

V Borah, P N Shah, S N Ghosh, M B Sampat, D J Jussawalla.   

Abstract

Based on the Barr body frequency, a total of 285 unselected breast cancer tissues were categorised as negative and positive tumours; incidence of these two groups in our series was 2:1, respectively. When 2-years' disease-free interval and 10-years' survival were considered, it was seen that patients harbouring negative tumours had significantly early recurrence and shorter duration of survival as compared to those having positive tumours. As vascular spread is the prerequisite of early recurrence, the shorter survival in the patients having negative tumours could be explained on the basis of blood vessel invasion, in that 73% of the negative tumours had blood vessel invasion, in contrast to only 24% in the positive tumours.

Entities:  

Mesh:

Year:  1980        PMID: 7351835     DOI: 10.1002/jso.2930130102

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

Review 1.  Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.

Authors:  Dawn M Carone; Jeanne B Lawrence
Journal:  Semin Cancer Biol       Date:  2012-06-18       Impact factor: 15.707

2.  Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.

Authors:  Jun Kang; Hee Jin Lee; Jiyoung Kim; Jae Jun Lee; Lee-so Maeng
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

3.  Breast cancer, prostaglandins and patient survival.

Authors:  A Bennett; I F Stamford; D A Berstock; F Dische; L Singh; R P A'Hern
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

Review 4.  Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies.

Authors:  Stephanie Weng; Samuel A Stoner; Dong-Er Zhang
Journal:  Oncotarget       Date:  2016-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.